At a glance
- Originator Toyama Chemical
- Class Neuroprotectants; Nootropics
- Mechanism of Action Neurotransmitter stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Amyotrophic lateral sclerosis; Glaucoma
Most Recent Events
- 01 Jul 2008 Toyama Chemical has been acquired by FUJIFILM Holdings Corporation
- 27 Jun 2005 Discontinued - Preclinical for Amyotrophic lateral sclerosis in USA (unspecified route)
- 27 Jun 2005 Discontinued - Preclinical for Glaucoma in Japan (unspecified route)